CTOs on the Move

Metamason

www.metamason.com

 
Metamason is dedicated to improving healthcare through technological innovation. Our health-focused software platform uses 3D scans of the body to create individually customized, 3D-printed products engineered for flawless fit.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.metamason.com
  • 811 W 7th St Suite 1146
    Los Angeles, CA USA 90017
  • Phone: 800.555.4455

Executives

Name Title Contact Details

Similar Companies

National Optronics SE

National Optronics SE is a Charlottesville, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dialyze Direct

Dialyze Direct provides staff assisted home hemodialysis services to elderly patients with End Stage Renal Disease who reside in Nursing Homes. Our mission is to deliver innovative and compassionate dialysis care to geriatric patients in Skilled Nursing Facilities, enhancing their quality of life while significantly reducing overall costs by improving outcomes, eliminating transportation and minimizing re-hospitalizations. The Dialyze Direct program permits an unprecedented degree of on-site coordination of care and sharing information with the nursing home staff, with respect to ESRD care, that include nursing, dietary and social work collaboration. Dialyze Direct has re-purposed home dialysis technology, with enhanced and proprietary protocols that are better suited to the special needs of geriatric patients with multiple co-morbid conditions resulting in improved outcomes, shortened recovery times, increased rehab score gains and decreased re-hospitalizations.

B and B Medical Technologies Inc

B and B Medical Technologies Inc is a Loomis, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardiosom

Cardiosom is a Carmel, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Smith and Nephew

Smith & Nephew is a global advanced medical technology business. We support healthcare professionals in more than 100 countries to improve the quality of life for their patients. Since 1856, when our founder T.J. Smith developed a new method for refining cod liver oil, and in World War One when his nephew led the supply of wound care products, to the present day, Smith & Nephew continues to pioneer health solutions. Through our market leadership positions in Sports Medicine, Trauma, Orthopaedic Reconstruction and Advanced Wound Management, our 16,000 employees continue to improve outcomes and expand access, constantly striving to create value for healthcare professionals, patients, payers and shareholders. Annual sales in 2016 were more than $4.6 billion. We are a constituent of the UK’s FTSE100 and our shares are traded on London Stock Exchange and through American Depository Receipts on the New York Stock Exchange   We have leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma.   We have almost 11,000 employees and a presence in more than 90 countries.   Annual sales in 2013 were more than $4.3 billion.   We are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN)